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ABSTRACT Spt10 is a putative acetyltransferase of Saccharomyces cerevisiae that directly activates the
transcription of histone genes. Deletion of SPT10 causes a severe slow growth phenotype, showing that
Spt10 is critical for normal cell division. To gain insight into the function of Spt10, we identiﬁed mutations
that impair or improve the growth of spt10 null (spt10D) mutants. Mutations that cause lethality in combi-
nation with spt10D include particular components of the SAGA complex as well as asf1D and hir1D. Partial
suppressors of the spt10D growth defect include mutations that perturb cell-cycle progression through the
G1/S transition, S phase, and G2/M. Consistent with these results, slowing of cell-cycle progression by
treatment with hydroxyurea or growth on medium containing glycerol as the carbon source also partially
suppresses the spt10D slow-growth defect. In addition, mutations that impair the Lsm1-72Pat1 complex,
which regulates decapping of polyadenylated mRNAs, also partially suppress the spt10D growth defect.
Interestingly, suppression of the spt10D growth defect is not accompanied by a restoration of normal
histone mRNA levels. These ﬁndings suggest that Spt10 has multiple roles during cell division.
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The Saccharomyces cerevisiae Spt10 protein plays important roles in
gene expression and growth. Mutations in the SPT10 gene have been
identiﬁed in many different ways, including as suppressors of the
transcriptional defects caused by Ty and Ty LTR insertion mutations
(Fassler and Winston 1988; Natsoulis et al. 1991), suppressors of
glucose repression of ADH2 (Denis and Malvar 1990), and suppres-
sors of loss of an upstream activation sequence (Prelich and Winston
1993; Yamashita 1993). Several subsequent studies have demonstrated
that Spt10 is a site-speciﬁc DNA binding protein that binds cooper-
atively at the regulatory regions of the four S. cerevisiae histone loci
where it activates transcription (Dollard et al. 1994; Eriksson et al.
2005, 2011; Hess et al. 2004; Mendiratta et al. 2006, 2007; Xu et al.
2005). DNA binding is dependent upon both a zinc ﬁnger domain
and an adjacent region required for cooperative binding (Mendiratta
et al. 2006, 2007). Spt10 also plays a negative role in histone gene
transcription, as it is required for repression of several histone loci
outside of S phase (Sherwood and Osley 1991). An intriguing feature
of the Spt10 amino acid sequence is a conserved acetyltransferase
domain (Neuwald and Landsman 1997). Although this domain is
required for Spt10 function (Hess et al. 2004), no acetyltransferase
activity or acetyltransferase substrates have yet been identiﬁed for
Spt10, despite efforts by several laboratories.
The SPT21 gene is functionally related to SPT10.M u t a t i o n si n
SPT21 were isolated in two of the same mutant selections as mutations
in SPT10 (Natsoulis et al. 1991; Prelich and Winston 1993), including
one large-scale selection that identiﬁed only these two genes (Natsou-
lis et al. 1991). In addition, mutations in SPT21 appear to cause the
same pattern of histone locus transcription defects as do mutations in
SPT10 (Dollard et al. 1994; Hess et al. 2004; Sherwood and Osley
1991). In vivo, Spt21 is also recruited to all four histone loci, and this
recruitment is required for the recruitment of Spt10 during S-phase
(Hess et al. 2004). Mutations in SPT10 and SPT21 share other phe-
notypes, including silencing defects (Chang and Winston 2011).
Mutations have been identiﬁed in SPT10 that suppress the require-
ment for SPT21,s u g g e s t i n gt h a tSpt21 is an accessory factor, required
for optimal Spt10 function (Hess et al. 2004).
In addition to the close functional relationships between SPT10 and
SPT21, obvious differences between them suggest that they do not
always function together. There are three especially striking differences
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Volume 3 | March 2013 | 573between the two. First, SPT10 is transcribed throughout the cell cycle,
whereas SPT21 is transcribed only during S phase, at the same time
as histone genes (Cho et al. 1998; Spellman et al. 1998). Second,
a complete deletion of SPT10 (spt10D) causes a severe growth defect,
whereas a complete deletion of SPT21 (spt21D) causes a only a mild
growth defect (Natsoulis et al. 1994). Finally, mutations that suppress
an spt21D mutation do not suppress spt10D and, in fact, sometimes
cause lethality when combined with spt10D (Hess and Winston 2005).
Taken together, the common and distinct phenotypes of spt10D and
spt21D mutants suggest that Spt10 and Spt21 function together to
regulate histone gene expression and that, in addition, Spt10 plays
other roles that are critical for normal growth.
To gain insight into other possible roles for Spt10, we have screened
for both enhancers and suppressors of the spt10D growth defect. The
identiﬁcation of mutations that cause lethality when combined with
spt10D suggests that Spt10 has overlapping roles with the SAGA coac-
tivator complex. In addition, Spt10 appears to be functionally related to
Asf1, the Hir complex, and the Caf-1 complex, whose functions are
connected in histone gene regulation, transcriptional silencing, and
chromatin assembly (Amin et al. 2012; Eriksson et al. 2012; Kaufman
et al. 1998; Sutton et al. 2001). The identiﬁcation of partial suppressors
of the spt10D growth defect suggests that Spt10 plays important roles
throughout the cell cycle. In support of the idea that these functions are
independent of the role of Spt10 as an activator of histone gene tran-
scription, suppressors of the spt10D growth defect do not reverse the
defects in histone gene transcription.
MATERIALS AND METHODS
Yeast strains, media, and crosses
All S. cerevisiae strains (Table 1) are GAL2+ derivatives of the S288C
background (Winston et al. 1995). Capital letters denote wild-type
genes, lowercase letters denote mutant alleles, and D indicates a com-
plete open reading frame deletion. To construct spt10D haploids, the
open reading frame of SPT10 was ﬁrst replaced with the LEU2 gene or
a kanamycin resistance marker in a diploid strain. Then, plasmid
pFW217 (SPT10-URA3-CEN) was used to transform the diploid to
Ura+, followed by sporulation of the diploid to obtain haploids with
the spt10D mutation and pFW217. Whenever possible, spt10D strains
were grown in the presence of pFW217 to minimize selection for
spontaneous growth suppressors. Then, the spt10D phenotypes were
tested after growth on medium with 5-ﬂuoroorotic acid (5-FOA) to
select for cells that had lost pFW217. For the nap1D::kanMX, hsl1D::
kanMX, mih1D::kanMX, swe1D::kanMX,a n dpat1D::kanMX alleles,
a 2.4-kb cassette was ampliﬁed by polymerase chain reaction (PCR)
from genomic DNA isolated from the corresponding deletion set
strain (Giaever et al. 2002), then used to transform a wild-type strain.
The cassette contains a replacement of the entire open reading frame
with a kanamycin resistance marker. The cln3D::HIS3, lsm1D::natMX,
and bck2D::hphMX alleles were generated by PCR-mediated disrup-
tion of the entire open reading frame (Goldstein and McCusker 1999).
All deletions were conﬁrmed by PCR. The cdc28-T18A Y19F allele was
generated by digesting p433 (a generous gift from A. Amon) with
EcoRI and using the fragment containing the cdc28-T18A Y19F allele
and the URA3 marker to transform a wild-type strain. The URA3 gene
was then replaced with the KanMX drug resistance cassette of pRS400.
Media, basic yeast techniques, mating, sporulation, and tetrad dissec-
tion were as previously described (Rose et al. 1990). Crosses to test
double mutant lethality generally contained one parent with an spt10D
mutation and also carrying plasmid pFW217 (SPT10-URA3-CEN).
Double-mutant lethality was assayed by replica plating the spore col-
onies to 5-FOA plates to determine whether strains that had lost
pFW217 were viable.
Transposon mutagenesis screen
The transposon mutagenesis screen was performed as described
(Burns et al. 1994). In summary, the LEU2-marked library DNA
was digested with NotI, then used to transform strain FY2191. Trans-
formant colonies were selected on SC-Leu-Ura medium then replica
plated to 5-FOA medium to select for cells that had lost pFW217
(SPT10-URA3), leaving colonies containing the library insertion in
an spt10D genetic background. Colonies that failed to grow were
designated synthetic lethal candidates, and colonies growing more
quickly than FY2191 were designated growth suppressor candidates.
All candidates were puriﬁed to single colonies, which were then in-
dividually patched on SC-Leu medium followed by replica plating to
verify the growth phenotype. All candidates remaining after this
rescreening were puriﬁed and tested a third time. Each candidate
was then crossed to an spt10D leu2 strain to test whether the mutant
phenotype cosegregated with the LEU2 marker on the transposon. For
the conﬁrmed mutants, genomic DNA was isolated, and vectorette
PCR was used to identify the location of each transposon insertion
(Arnold and Hodgson 1991). As one growth suppressor candidate was
tightly linked to the SPT10 locus, instead of vectorette PCR, we used
a candidate gene approach and by a combination of PCR and se-
quencing, demonstrated the insertion to be within LSM1.
Synthetic genetic array (SGA) screen
A collection of yeast strains containing deletions of every nonessential
gene was screened for phenotypes in an spt10D background using an
SGA screen (Tong et al. 2001). The collection was spotted onto YPD
plates with deletion set strains hoD::KanMX, lys2D::KanMX,a n d
lys12D::KanMX spotted separately at the top and bottom of each plate
as controls that do not affect spt10D growth. The array was mated by
replica plating to a lawn with an spt10D strain (FY2923) containing
a can1::STE2pr-HIS3 allele and carrying the pFW217 (SPT10-URA3)
plasmid. Diploids were selected on SC-Leu-Ura and sporulated on
solid 1% potassium acetate medium supplemented with histidine,
uracil, leucine, and lysine. MATa haploids that contain the deletion
set mutation, spt10D, and the SPT10 plasmid were selected by replica
plating onto SC-Arg-His-Leu-Ura+canavanine+G418 medium. The
cells were then replica plated to SC + 5-FOA medium to leave the
mutant spt10D as the only SPT10 allele present. Strains with better or
worse growth compared with the control strains were identiﬁed and
retested, and then tetrads were dissected to assay for 2:2 segregation
and cosegregation of the suppression phenotype with the kanamycin
resistance marker.
Dilution spot tests
For dilution spot tests, unless noted otherwise, strains harboring the
pFW217 (SPT10-URA3-CEN) plasmid were single colony puriﬁed on
5-FOA medium to select for plasmid loss, and single colonies were
then patched to YPD media. After 2 d, the cells were resuspended in
water to a density of 4 · 106 cells/mL (Figure 2) or 1 · 107 cells/mL
(Figures 1, 326). Fivefold serial dilutions were spotted onto the media
indicated. Plates were scanned after 223da t3 0  , unless otherwise
indicated.
cDNA synthesis and real-time PCR
RNA was extracted from 10 mL of yeast cultures in exponential
growth as described (Ausubel et al. 1988; Swanson et al. 1991). Then,
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Name Genotype
FY2191 MATa spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1 + pFW217 (SPT10-URA3-CEN)
FY2915 MATa hsl7-gs65f::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2916 MATa hsl7-gs63f::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2917 MATa lsm1-68f::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2918 MATa asf1-69c::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2919 MATa asf1-57b::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2920 MATa ydr333c-710a::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2921 MATa dbf2-719a::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2922 MATa lea1-719d::Tn3-LEU2 spt10D201::HIS3 lys2-128d ura3-52 his3D200 leu2D1
FY2923 MATa spt10D::LEU2 can1D::STE2pr-HIS3 lys2-128d ura3D0 his3D1o rD200 leu2D0 lyp1D or LYP1 + pFW217
(SPT10-URA3-CEN)
FY2200 MATa lys2-128d ura3D0 his3D200 leu2D0
FY2924 MATa spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2925 MATa spt8-302::LEU2 spt10D::kanMX lys2-128d or LYS2-173R2 ura3-52 leu2D1 trp1D63 + pFW217
(SPT10-URA3-CEN)
FY2926 MATa spt20D200::ARG4 spt10D::LEU2 lys2-128d or LYS2-173R2 ura3D0 or -52 leu2D0 + pFW217
(SPT10-URA3-CEN)
FY2927 MATa gcn5D::HIS3 spt10D::LEU2 ura3D0 or ura3-52 his3D200 leu2D0 or leu2D1 his3D200 + pFW217
(SPT10-URA3-CEN)
FY2928 MATa ubp8D::kanMX4 spt10D::LEU2 lys2-128d or LYS2-173R2 ura3D0 or -52 his3D200 leu2D0 or leu2D1 arg4-12 + pFW217
(SPT10-URA3-CEN)
FY2482 MATa spt21D::kanMX lys2-128d ura3D0 his3D200 leu2D0
FY2929 MATa (hta2-htb2)D::URA3 hhf2D::LEU2 ura3-52 his3D200 leu2D1
FY2930 MATa hsl7D::HIS3 spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2931 MATa nap1D::kanMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2932 MATa bck2D::hphMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2933 MATa lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2934 MATa hsl7D::HIS3 ura3D0 his3D200 leu2D0
FY2935 MATa nap1D::kanMX lys2-128d ura3D0 his3D200 leu2D0
FY2936 MATa bck2D::hphMX lys2-128d ura3D0 his3D200 leu2D0
FY2937 MATa lsm1D::natMX lys2-128d ura3D0 his3D200 leu2D0
FY2938 MATa spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2939 MATa hsl7D::HIS3 nap1D::kanMX spt10D::LEU2 ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2940 MATa hsl7D::HIS3 bck2D::hphMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2941 MATa hsl7D::HIS3 lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY2942 MATa nap1D::kanMX bck2D::hphMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2943 MATa nap1D::kanMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2944 MATa bck2D::hphMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY2945 MATa hsl7D::HIS3 nap1D::kanMX bck2D::hphMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217
(SPT10-URA3-CEN)
FY2946 MATa hsl7D::HIS3 nap1D::kanMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY2947 MATa hsl7D::HIS3 bck2D::hphMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY2948 MATa nap1D::kanMX bck2D::hphMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY2949 MATa hsl7D::HIS3 nap1D::kanMX bck2D::hphMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY1856 MATa lys2-128d ura3D0 his3D200 leu2D0
FY2950 MATa hsl7D::HIS3 spt10D::LEU2 ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2951 MATa hsl1D::kanMX4 spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2952 MATa mih1D::kanMX4 spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2953 MATa swe1D::kanMX4 spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2954 MATa hsl7D::HIS3 swe1D::kanMX4 spt10D::LEU2 ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2955 MATa hsl1D::kanMX4 lys2-128d ura3D0 his3D200 leu2D0
FY2956 MATa mih1D::kanMX4 lys2-128d ura3D0 his3D200 leu2D0
FY2957 MATa swe1D::kanMX4 lys2-128d ura3D0 his3D200 leu2D0
FY2958 MATa cdc28-T18A Y19F:kanMX lys2-128d ura3D0 his3D200 leu2D0
FY2959 MATa cdc28-T18A Y19F:kanMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2960 MATa hsl7D::HIS3 cdc28-T18A Y19F:kanMX spt10D::LEU2 ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2961 MATa hsl7D::HIS3 cdc28-T18A Y19F:kanMX lys2-128d ura3D0 his3D200 leu2D0
FY2962 MATa cln3D::HIS3 lys2-128d ura3D0 his3D200 leu2D0
FY2963 MATa cln3D::HIS3 spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2964 MATa pat1D::kanMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2965 MATa pat1D::kanMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2966 MATa pat1D::kanMX4 lys2-128d ura3D0 his3D200 leu2D0
(continued)
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kit, Ambion) and reverse transcribed with Superscript III reverse
transcriptase (Invitrogen) using an oligo-dT primer. Real-time PCR
was performed with a Stratagene MX3000P machine using 50 ng of
cDNA and 1 mg of each primer per 50 mL of reaction, with each
reaction performed in triplicate. Primer sequences (Table 2) were
provided by Neil McLaughlin and David Clark (personal communi-
cation). The speciﬁcity of each primer pair was conﬁrmed using the
corresponding deletion mutant. Thermocycling parameters were:
10:00 at 94 ,t h e n3 5 240 cycles of (0:30 at 94 ,0 : 3 0a t5 2  ,1 : 0 0a t
72 ), followed by a melting curve to assay product speciﬁcity. Linearity
and efﬁciency was conﬁrmed for each primer pair on each plate.
RESULTS
Identiﬁcation of mutations that enhance or suppress the
spt10D slow-growth phenotype
To study the basis of the spt10D slow growth phenotype, we screened
for mutations that enhance or suppress the growth defect by using
both transposon insertion mutagenesis (Burns et al. 1994) and the S.
cerevisiae deletion set (Giaever et al. 2002), both as described in
Materials and Methods. As spontaneous suppressors of the spt10D
slow growth phenotype arise at a high frequency, we maintained
al o w - c o p ySPT10 plasmid (pFW217) in the spt10D strains until the
ﬁnal screening step for each method.
We began with a transposon insertion mutagenesis screen (Burns
et al. 1994; Kumar and Snyder 2002) in which we tested 9000 in-
dependent transformants for improved or impaired growth compared
with the spt10D parent (Materials and Methods). By this approach, we
identiﬁed eight mutations in a total of six genes (Table 3). Three
mutations that confer suppression of spt10D poor growth were in
two genes and ﬁve mutations that cause lethality when combined with
spt10D were identiﬁed in four genes. For all six genes, we tested
a complete deletion of the identiﬁed gene and found the same sup-
pression phenotype, suggesting that all of the insertion mutations
cause null phenotypes. For all subsequent experiments, the deletion
mutations were used.
From this initial screen, a concern of bias arose, as we had obtained
two different transposon insertions within ASF1 without obtaining
any insertions in other genes whose deletions were previously shown
to be lethal in combination with spt10D. These genes include HTA1,
HTB1, HHF1, HIR1, ASF1, RKR1,a n dMBP1 (Braun et al. 2007;
Fassler and Winston 1988; Hess 2004; Hess and Winston 2005; Sutton
et al. 2001). Therefore, rather than saturate the transposon mutagen-
esis screen, which would require testing 30,000 transformants (Burns
et al. 1994), we switched to the more systematic approach of screening
the deletion set.
We screened the deletion set for mutations that either suppress or
enhance the spt10D slow growth defect (Materials and Methods). Our
screen yielded 44 mutations that cause lethality in combination with
spt10D (Table 4) and 13 mutations that improve spt10D growth (Table
5). Interestingly, there was no overlap with the mutations identiﬁed
from the transposon mutagenesis screen, although some functionally
related genes were identiﬁed (LSM genes). The lack of overlap indi-
cates that the deletion set screen had many false-negative results.
There was also a class of 12 mutants that appeared to cause lethality
during the original screen but showed little or no growth defect upon
Table 1, continued
Name Genotype
FY2967 MATa mec1D::LEU2 sml1D::HIS3 lys2-128d ura3D0 his3D200 leu2D0
FY2816 MATa spt21D::HIS3 lys2-128d ura3D0 his3D200 leu2D0
FY2817 MATa spt21D::HIS3 lys2-128d ura3D0 his3D200 leu2D0
FY2968 MATa nap1D::kanMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2969 MATa bck2D::hphMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2970 MATa lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0 + pFW217 (SPT10-URA3-CEN)
FY2971 MATa hsl7D::HIS3 lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY2972 MATa hsl7D::HIS3 bck2D::hphMX lsm1D::natMX spt10D::LEU2 lys2-128d ura3D0 his3D200 leu2D0
FY1924 MATa hsl7D::HIS3 ura3D0 his3D200 leu2D0 trp1D63
FY2973 MATa nap1D::kanMX lys2-128d ura3D0 his3D200 leu2D0
FY2974 MATa bck2D::hphMX lys2-128d ura3D0 his3D200 leu2D0
FY2975 MATa lsm1D::natMX lys2-128d ura3D0 his3D200 leu2D0
FY2978 MATa spt10D::KanMX leu2D1 ura3-52 lys2-128d his3D200 + pFW217 (SPT10-URA3-CEN)
FY2979 MATa asf1D::HIS3 leu2D0 ura3D0 lys2-128d his3D200
FY2980 MATa hir1D::LEU2 his4-912d HIS3 ura3D0 or ura3-52 lys2-128d leu2D0 or leu2D1
FY2981 MATa spt21D::HIS3 ura3D0 leu2D0 lys2-128d his3D200
FY2982 MATa asf1D::HIS3 ura3D0 leu2D0 lys2-128d his3D200
FY2903 MATa cac1D::KanMX leu2D0 ura3D0 lys2-128d his3D200
FY2933 MATa spt21D::HIS3 ura3D0 leu2D0 lys2-128d his3D200
FY1235 MATa hir1D::LEU2 leu2D1 ura3-52 lys2-128d his4-912d trp1D63
n Table 2 Primers used to measure histone mRNA levels
Primer Gene Orientation Sequence
FO6006 HTA1 Forward TTCAAAACAAACAAATTTCA
FO6007 HTA1 Reverse AAATACCAGAACCGATCTTA
FO6008 HTA2 Forward GGAAAGTACAGAACAAGAGC
FO6009 HTA2 Reverse CTTTGTTTCTTTTCAACTCAG
FO6010 HTB1 Forward CAAACCACAAATAAACCATAC
FO6011 HTB1 Reverse AGGAAGTGATTTCATTATGC
FO6012 HTB2 Forward ACCAACAACAACTTACTCTACA
FO6013 HTB2 Reverse AATCACAATACCTAGTGAGTGA
FO6014 HHT1 Forward TATATAAACGCAAACAATGG
FO6015 HHT1 Reverse AACTGATGACAATCAACAAA
FO6016 HHT2 Forward TACTAAAGGATCCAAGCAAA
FO6017 HHT2 Reverse AAAAATTCCCGCTTTATATT
FO6018 HHF1 Forward AACAAACAAAAACAAGCAAC
FO6019 HHF1 Reverse TTGTTGTTACCGTTTTCTTA
FO6020 HHF2 Forward GTAGCAAAAACAACAATCAA
FO6021 HHF2 Reverse ATAATTTCAAACACCGATTG
FO6145 ACT1 Forward TTTTGTCCTTGTACTCTTCC
FO6146 ACT1 Reverse CTGAATCTTTCGTTACCAAT
576 | J. S. Chang and F. Winstontetrad dissection (discussed in the section Genes involved in silencing
show mutant phenotypes in combination with spt10D).
The loss of speciﬁc classes of SAGA genes is lethal in
combination with spt10D
Our screens identiﬁed four genes encoding components of the SAGA
coactivator complex whose deletion is lethal when combined with
spt10D: SPT3, SPT8, SGF11, and SGF29. These four factors are be-
lieved to be involved in distinct activities of the multifunctional SAGA
complex, as Spt3 and Spt8 modulate the recruitment of the TATA-
binding protein (TBP) to promoters (Bhaumik and Green 2001, 2002;
Dudley et al. 1999; Larschan and Winston 2001), Sgf11 is part of the
DUB module of SAGA (Kohler et al. 2010; Samara et al. 2010), and
Sgf29 has recently been shown to bind to H3K4me2/3, to be required
for Gcn5-dependent histone acetylation in vivo, and to help recruit
TBP to promoters (Bian et al. 2011; Shukla et al. 2012). To test
whether the double-mutant lethality with spt10D is general for all
SAGA deletion mutants or speciﬁc for certain classes, we tested dele-
tions of SPT20, encoding a core component of SAGA, UBP8,e n c o d i n g
a histone deubiquitylase, and GCN5, encoding the histone acetyltrans-
ferase. Our results (Figure 1) show that the spt20D spt10D double
mutant is inviable, whereas both the ubp8D spt10D and gcn5D spt10D
double mutants are viable but grow poorly, even worse than the
spt10D single mutant. Our genetic analysis, then, demonstrates that
Spt10 shares essential or important roles with distinct functions of the
SAGA coactivator complex. In light of the spt10D-gcn5D genetic in-
teraction, we note that we did not see a genetic interaction between
spt10D and rtt109D (RTT109 encodes a histone acetyltransferase that
has been implicated in histone gene transcription) (Fillingham et al.
2009).
Double-mutant lethality of spt10D with asf1D and
hir/hpc2D mutations suggests functional overlaps
Among the genes identiﬁed as causing double-mutant lethality with
spt10D were asf1D, hir2D, hir3D,a n dhpc2D.P r e v i o u ss t u d i e sa l s o
showed that spt10D asf1D double mutants are inviable (Sutton et al.
2001). Asf1 has been shown to be a histone chaperone (Munakata
et al. 2000), the Hir complex (comprised of Hir1-3 and Hpc2)h a s
been implicated in chaperone and nucleosome assembly activities
(Green et al. 2005; Prochasson et al. 2005), and both Asf1 and the
Hir complex have been shown to regulate histone gene transcription
(Osley and Lycan 1987; Sutton et al. 2001; Xu et al. 1992). Further-
more, these factors are believed to function both physically and ge-
netically with each other and with the Caf-1 complex (Green et al.
2005; Kaufman et al. 1998; Liu et al. 2012; Sutton et al. 2001).
The isolation of asf1D and hir/hpc2D mutations as causing lethality
when combined with spt10D suggests that Spt10 participates in this set
of functions. To test this further, we crossed spt10D by hir1D and by
cac1/rlf2D (CAC1 encodes a component of the Caf-1 complex) to test
for double mutant lethality. Our results (Table 6) show that spt10D
causes inviability with asf1D and hir/hpc mutations, but not with
cac1D. This pattern is reminiscent of earlier studies that showed that
both asf1D and hir/hpc mutations cause double-mutant sickness with
cac mutations, but not with each other (Kaufman et al. 1998; Sutton
et al. 2001). We note that our screens did not identify mutations in
RTT106, which encodes a histone chaperone that has been shown to
regulate histone gene transcription by interactions with Asf1/Hir/Caf-1
(Fillingham et al. 2009; Huang et al. 2007; Kurat et al. 2011; Silva
et al. 2012; Zunder and Rine 2012). Similarly, a screen for mutations
that cause double-mutant lethality with rtt106D did not identify
spt10D (Imbeault et al. 2008). In contrast to spt10D,a nspt21D
mutation allowed viability when combined with hir1D or asf1D
(Table 6). Taken together, our results suggest that Spt10, but not
Spt21, contributes to an essential function in collaboration with Asf1
and the Hir complex, likely either in histone gene activation or an
aspect of chromatin assembly.
Genes involved in silencing show mutant phenotypes in
combination with spt10D
One notable class of mutants appeared to show lethality in
combination with spt10D during our systematic screen. However,
upon retesting by tetrad dissection, viable double mutant spores were
obtained at the expected frequency, without substantial growth
defects. This class of mutants included sir1D, ard1D,a n dpol32D,a l l
of which have roles in silencing (Pillus and Rine 1989; van Welsem
et al. 2008; Whiteway et al. 1987). Others have reported a similar
pattern of apparent lethality for sir1D dot1D and pol32D dot1D in
another deletion set screen (van Welsem et al. 2008). They discovered
that the pattern actually resulted from mating type silencing defects,
which prevent growth when the SGA screening method is used. Our
studies of Spt10 have demonstrated it to be required for silencing
(Chang and Winston 2011).
The slow growth of spt10D mutants can be suppressed
through multiple genetic pathways
The mutations that we identiﬁed that suppress the spt10D growth
defect fall into several functional categories. For the remainder of
our analysis, we focused on the four mutations that individually
caused the strongest suppression of the spt10D growth defect: hsl7D,
nap1D, bck2D,a n dlsm1D (Figure 2). Hsl7 is an arginine methyltrans-
ferase with a role in the bud morphogenesis checkpoint (Lew 2000).
Nap1 is a histone chaperone involved in the nuclear import of histo-
nes, and it regulates cell-cycle progression in G2/M (Zlatanova et al.
2007). Bck2 regulates the transition from G1 to S phase of the cell
cycle (Epstein and Cross 1994; Lee et al. 1993), and Lsm1 is part of
a heteroheptameric complex involved in RNA decapping and
n Table 3 Genes identiﬁed by a transposon screen
Gene
Effect When Combined
With spt10D
Insertion Location
Relative to ATG Description
HSL7 Improved growth +1232 Arginine N-methyltransferase involved in regulation of Swe1 degradation
HSL7 Improved growth +1654 Arginine N-methyltransferase involved in regulation of Swe1 degradation
LSM1 Improved growth 2191 Part of a complex involved in degradation of cytoplasmic mRNAs
ASF1 Lethality +102 Histone chaperone
ASF1 Lethality +283 Histone chaperone
YDR333C Lethality +530 Unknown function
DBF2 Lethality +1475 Ser/Thr kinase; exit from mitosis
LEA1 Lethality +361 Component of U2 snRNP
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histone mRNA stability (Herrero and Moreno 2011). All of the de-
letion mutations are partial suppressors individually, but when lsm1D
is combined with hsl7D or bck2D,s t r o n ga d d i t i v ee f f e c t sa r es e e n
(Figure 2). Little or no additivity is seen with other combinations.
This ﬁnding suggests that hsl7D and bck2D suppress the spt10D
growth defect through a different genetic pathway than does lsm1D.
To study these effects, we conducted a more detailed genetic analysis
of each suppressor.
Perturbations of the G2/M transition allow spt10D
mutants to grow faster
HSL7, along with HSL1, initially was isolated in a histone synthetic
lethal screen, which identiﬁed genes that become essential when the
tail of either histone H3 or histone H4 is deleted (Ma et al. 1996).
Although the basis of this synthetic lethality remains unknown, Hsl1,
a protein kinase, and Hsl7 have been shown to regulate the bud
morphogenesis checkpoint through the Hsl2Swe12Cdc28 pathway,
which monitors whether cytoskeletal events have been properly com-
pleted prior to mitosis (Figure 3A) (Lew 2000). The cyclin-dependent
kinase Cdc28 controls cell-cycle progression through the G2/M tran-
sition; its activity is inhibited by the kinase Swe1 and activated by the
phosphatase Mih1.W h e na nS. cerevisiae cell buds, Hsl1 recruits Hsl7
to the bud neck and phosphorylates both proteins. This recruits Swe1,
leading to Swe1 degradation, causing decreased phosphorylation of
Cdc28 and thereby promoting progression through G2/M. Thus, an
n Table 4 Genes found by SGA analysis whose deletion causes
double-mutant lethality or extreme sickness with spt10D
Gene Description
BCK1 MAP KKK in the protein kinase C signaling pathway
BUD20 Protein involved in bud site selection
CAC2 Component of chromatin assembly complex CAF-I
CTF19 Component of the COMA complex
CYS3 Cysteine biosynthesis
DOA1 Ubiquitin-mediated protein degradation
ELP2 Component of the Elongator complex
ELP4 Component of the Elongator complex
ELP6 Component of the Elongator complex
HHF1 Histone H4
HHT1 Histone H3
HIR2 Component of the HIR complex
HIR3 Component of the HIR complex
HIT1 Function unknown
HPC2 Component of the HIR complex
IES2 Associates with the INO80 chromatin remodeling
complex
IXR1 Binds DNA containing intrastrand cross-links formed
by cisplatin
MCM21 Component of the COMA complex
MDM20 Component of the NatB N-terminal acetyltransferase
MRPL38 Mitochondrial ribosomal protein of the large
component
MSD1 Mitochondrial aspartyl-tRNA synthetase
NHX1 Endosomal Na+/H+ exchanger
PEP7 Facilitates vesicle-mediated vacuolar protein sorting
PGD1 Component of the mediator complex
REG1 Negative regulation of glucose-repressible genes
RMD8 Cytosolic protein required for sporulation
SAM37 Component of the mitochondrial SAM complex
SGF11 Component of the SAGA complex
SGF29 Component of the SAGA complex
SIN3 Component of the Rpd3-Sin3 complex
SLX8 Component of the Slx5-Slx8 SUMO-targeted
ubiquitin ligase complex
SOD1 Cytosolic copper-zinc superoxide dismutase
SPT3 Component of the SAGA complex
SPT8 Component of the SAGA complex
SWC3 Component of the SWR1 complex
TAF14 Component of TFIID, TFIIF, INO80, SWI/SNF,
and NuA3 complexes
THR1 Threonine synthesis
THR4 Threonine synthase
UMP1 Chaperone required for maturation of the 20S
proteasome
VMA8 Component of the peripheral membrane domain
of the vacuolar H+-ATPase
VMS1 Protein degradation and quality control
VPS54 Component of the GARP complex
YAF9 Component of both the NuA4 histone H4 and
SWR1 complexes
YGL149W Dubious open reading frame, overlaps INO80
n Table 5 Genes found by SGA analysis whose deletion
suppresses the spt10D poor growth phenotype
Gene Description
BCK2 Protein kinase C signaling pathway and the G1/S
transition
CLB2 B-type cyclin involved in G2 to M progression
HAL5 Putative protein kinase
HDA2 Component of a class II histone deacetylase complex
IES3 Component of the INO80 complex
ITR1 Myo-inositol transporter
LAS21 Synthesis of the glycosylphosphatidylinositol (GPI)
core structure
LSM6 Part of complexes involved in RNA processing, splicing,
and decay
LSM7 Part of complexes involved in RNA processing, splicing,
and decay
NAP1 Bud morphogenesis, microtubule dynamics, and
transport of histones H2A and H2B
SIF2 Component of the Set3C complex
SLM4 Component of the EGO complex
SYH1 Protein of unknown function, inﬂuences nuclear pore
distribution
Figure 1 Mutations in genes encoding SAGA subunits lead to lethality
or poor growth in an spt10D background. Shown are ﬁvefold dilution
spot tests. All strains were grown to saturation in SC-Ura medium in the
presence of the pFW217 SPT10-URA3-CEN plasmid. They were seri-
ally diluted ﬁvefold and spotted onto SC-Ura and 5-FOA plates to
select for cells that have maintained or lost the SPT10 plasmid, re-
spectively. The SC-Ura plate is shown after 2 d of incubation at 30 
and the 5-FOA plate after 5 d. Upper and lower panels are from the
same plate. The strains were wild type (FY2200), spt10D (FY2924),
spt8D spt10D (FY2925) spt20D spt10D (FY2926), gcn5D spt10D
(FY2927), and ubp8D spt10D (FY2928).
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Cdc28 activity. We tested the effects of other mutations in the
Hsl2Swe12Cdc28 pathway on spt10D growth. Consistent with our
ﬁndings for hsl7D,b o t hhsl1D and mih1D, which also impair pro-
gression through the bud morphogenesis checkpoint, suppress the
spt10D growth defect, whereas a mutation (swe1D) that promotes
progression does not (Figure 3B). As additional evidence that impair-
ment of G2/M progression suppresses the spt10D growth defect, we
identiﬁed clb2D as a suppressor in our screen (Table 5).
To test whether suppression of the spt10D growth defect by hsl7D
occurs within the Hsl2Swe12Cdc28 pathway, we tested combina-
tions of mutations in this pathway. First, we found that swe1D is
epistatic to hsl7D with respect to suppression of the spt10D growth
defect (Figure 3B), suggesting that suppression by hsl7D is mediated
through Swe1 activity. Second, we tested whether the inhibitory phos-
phorylation of Cdc28 by Swe1 plays a role in hsl7D suppression of the
spt10D growth defect. To do this, we used the cdc28-T18A Y19F allele
(Amon et al. 1992; Sorger and Murray 1992), which makes cells in-
sensitive to mutations upstream in the Hsl-Swe1-Cdc28 pathway, thus
mimicking loss of Swe1. We found that hsl7D no longer suppresses
the spt10D growth defect in the presence of the cdc28-T18A Y19F
allele (Figure 3C), further supporting that hsl1D-a n dhsl7D-mediated
suppression occurs through the Hsl2Swe12Cdc28 pathway. Taken
together, our genetic analysis suggests that mutations that activate the
bud morphogenesis checkpoint can confer improved growth of spt10D
cells.
Perturbations at the G1/S transition also suppress
the spt10D growth defect
Bck2 was originally isolated as a factor important in protein kinase C
signaling, and it has been found to be important in controlling the G1/
S transition of the cell cycle (Epstein and Cross 1994; Lee et al. 1993).
A related protein involved in regulating the G1/S transition is Cln3,
ac y c l i nt h a tb i n d st oCdc28 to regulate the transition through START
(Richardson et al. 1989). We asked whether a cln3D mutation can also
suppress the spt10D growth defect. Spot tests demonstrate that cln3D
spt10D mutants grow better than spt10D single mutants (Figure 4),
suggesting that different perturbations in the G1/S transition can
suppress the spt10D growth defect. Taken together with the hsl7D
suppression data, our genetic analysis demonstrates that the spt10D
slow growth can be suppressed by mutations that delay cell cycle
progression at either the G1/S transition or the bud morphogenesis
G2/M checkpoint.
Impairment of the Lsm1-72Pat1 complex suppresses
the spt10D slow growth phenotype
Next we conducted a more detailed genetic analysis of three closely
related suppressors: lsm1D, lsm6D,a n dlsm7D. The eight S. cerevisiae
LSM (like Sm) genes form two distinct, ring-shaped, heteroeptameric
complexes (Tharun 2009). The ﬁrst complex, containing Lsm2-8,
localizes to the nucleus and regulates pre-mRNA splicing. The second
complex, containing Lsm1-7, is localized to the cytoplasm and regu-
lates the decapping of polyadenylated mRNAs, in conjunction with
Pat1 (protein associated with Topoisomerase II). We note that in both
larger eukaryotes (Tharun 2009) and in yeast (Herrero and Moreno
2011), the Lsm1-72Pat1 complex has been implicated in promoting
the degradation of histone mRNAs.
The result that lsm1D suppresses the spt10D slow growth pheno-
type suggests that it is the Lsm1-72Pat1 complex, rather than the
Lsm22Lsm8 complex that is related to spt10D growth. We therefore
also tested whether pat1D suppresses the spt10D growth phenotype.
Our results (Figure 5) show that pat1D does suppress the spt10D
n Table 6 spt10D is inviable with hir1D and asf1D
Double Mutant Phenotypea
spt10D hir1D Inviableb
spt10D asf1D Inviablec
spt10D cac1D Viabled
spt21D hir1D Viablee
spt21D asf1D Viablef
spt21D cac1D Viableg
a
The phenotype was determined by testing the ability of the double mutant to
survive loss of plasmid pFW217 (SPT10-URA3-CEN) by assaying growth on
5FOA plates as described in Materials and Methods. The cross done for each
combination is listed below.
b
FY2978 · FY1235.
c
FY2924 · FY2979.
d
FY2903 · FY2938.
e
FY2980 · FY2933.
f
FY2981 · FY2982.
g
FY2903 x FY2933.
Figure 2 Representative suppressors of the spt10D
slow growth phenotype. Shown are ﬁvefold dilution
spot tests. spt10D strains were cured of the pFW217
SPT10-URA3-CEN plasmid and grown as described in
Materials and Methods, then resuspended to 4 · 106
cells/mL. They were subjected to ﬁvefold dilutions,
spotted onto YPD medium, and photographed after 2
d. Strains were wild type (FY2200), spt21D (FY2482),
(hta2-htb2)D hhf2D (FY2929), spt10D (FY2924), hsl7D
spt10D (FY2930), nap1D spt10D (FY2931), bck2D
spt10D (FY2932), lsm1D spt10D (FY2933), hsl7D
(FY2934), nap1D (FY2935), bck2D (FY2936), lsm1D
(FY2937), spt10D (FY2938), hsl7D nap1D spt10D
(FY2939), hsl7D bck2D spt10D (FY2940), hsl7D lsm1D
spt10D (FY2941), nap1D bck2D spt10D (FY2942), nap1D
lsm1D spt10D (FY2943), bck2D lsm1D spt10D (FY2944),
hsl7D nap1D bck2D spt10D (FY2945), hsl7D nap1D
lsm1D spt10D (FY2946), hsl7D bck2D lsm1D spt10D
(FY2947), nap1D bck2D lsm1D spt10D (FY2948), and
hsl7D nap1D bck2D lsm1D spt10D (FY2949).
Volume 3 March 2013 | Modulators of spt10D Growth | 579growth defect and, furthermore, that suppression by lsm1D and pat1D
is not additive, suggesting that lsm1D and pat1D suppress the spt10D
growth defect through the same pathway. The other LSM genes in the
complex are essential for viability and could not be tested.
Environmental conditions that slow cell division also
suppress the spt10D slow growth phenotype
Considering that genetic means of slowing cell-cycle progression can
suppress the spt10D slow growth phenotype, we asked whether altered
growth conditions that slow cell cycle progression will also suppress
this phenotype. First, we assayed the growth of spt10D strains on
medium containing 25 mM hydroxyurea (HU), a ribonucleotide re-
ductase inhibitor that impedes S-phase progression. We found that
addition of 25 mM HU causes modest suppression of the spt10D
growth defect relative to wild-type growth (Figure 6A).
Second, we slowed growth using medium that contains glycerol
rather than glucose as a carbon source. Relative to wild-type, spt10D
growth modestly improves on this medium (Figure 6B). These ﬁnd-
ings are consistent with the possibility that slowing cell cycle progres-
sion through multiple means improves spt10D growth.
Suppressors of the spt10D growth phenotype
do not restore histone mRNA levels
Because Spt10 binds to histone gene promoters and regulates histone
gene transcription (Dollard et al. 1994; Eriksson et al. 2011; Hess et al.
2004; Sherwood and Osley 1991; Xu et al. 2005), we wanted to test
whether the suppressors improve spt10D growth by increasing histone
gene mRNA levels. We therefore measured mRNA levels for all eight
histone genes in the suppressor strains, using reverse transcription and
real-time PCR. We used primer pairs highly speciﬁc for their corre-
sponding transcripts (Table 2; N. McLaughlin and D. Clark, personal
communication) to distinguish the two nearly identical copies of each
histone gene.
Our results (Figure 7) show that the suppressors do not restore
histone mRNA levels in an spt10D background. First, in agreement
with previous results (Dollard et al. 1994; Hess et al. 2004), we found
that, in asynchronously growing cultures, HTA2 and HTB2 mRNA
levels are decreased approximately 20-fold, with more modest
decreases of HHT1, HHT2,a n dHHF2 mRNA levels. In an spt10D
background, no single suppressor mutation or multiple suppressor
combination restores mRNA levels for any histone gene. The only
substantial change with any suppressor mutation is a decrease in
HHF1 mRNA levels in spt10D mutants when LSM1 is deleted. This
is in spite of the ﬁnding that some of the suppressor mutations cause
modest changes in histone mRNA levels in a wild-type SPT10
Figure 3 Perturbed progression through the bud mor-
phogenesis checkpoint can suppress the spt10D growth
defect. (A) Diagram of the Hsl2Swe12Cdc28 pathway.
(B, C) Fivefold dilution spot tests. Each strain was grown
to saturation and diluted to 1.0 · 107 cells/mL for the
densest spot. Strains in (B) were wild type (FY2200),
spt10D (FY2924), hsl7D spt10D (FY2930), hsl1D spt10D
(FY2951), mih1D spt10D (FY2952), swe1D spt10D
(FY2953), hsl7D swe1D spt10D (FY2954), hsl7D
(FY2934), hsl1D (FY2955), mih1D (FY2956), and swe1D
(FY2957). Strains in (C) were wild type (FY2200), hsl7D
(FY2934), cdc28-T18A Y19F (FY2958), spt10D (FY2924),
hsl7D spt10D (FY2930), cdc28-T18A Y19F spt10D
(FY2959), hsl7D cdc28-T18A Y19F spt10D (FY2960),
and hsl7D cdc28-T18A Y19F (FY2961). Pictures were
taken after 2 d.
Figure 4 A mutation perturbing the G1/S transition can partially
suppress the spt10D growth defect. Fivefold dilution spot assays were
performed as in Figure 3. Strains were wild type (FY2200), cln3D
(FY2962), spt10D (FY2924), and cln3D spt10D (FY2963). Pictures were
taken after 2 d.
Figure 5 Suppression of the spt10D growth defect by mutations in the
Lsm1-7-Pat1 complex. Dilution spot assays were performed as in Fig-
ure 3 with the following strains: wild type (FY2200), spt10D (FY2924),
lsm1D spt10D (FY2933), pat1D spt10D (FY2964), lsm1D pat1D spt10D
(FY2965), lsm1D (FY2937), and pat1D (FY2966). Pictures were taken
after 2 d.
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lsm1D agrees with previous results (Herrero and Moreno 2011). Over-
all, our results suggest that restoration of normal histone mRNA levels
is not necessary for suppression of the spt10D slow growth phenotype.
We note that, like spt10Δ mutants, spt21Δ mutants show decreased
levels of HTA2, HTB2,a n dHHF2 mRNA, but unlike spt10Δ mutants
or the suppressor strains, the spt21Δ mutants show modest increases
in mRNA levels for HTA1, HTB1, HHF1, and to a lesser degree
HHT1. These results suggest that Spt10 and Spt21 have some non-
overlapping roles in histone gene regulation.
DISCUSSION
In this work, we have identiﬁed a broad spectrum of mutations that
either cause lethality when combined with spt10D or that suppress the
slow growth phenotype caused by spt10D.T h eﬁrst set of genes sug-
gests that the function of Spt10 partially overlaps with the SAGA
coactivator complex as well as with two factors involved in chromatin
assembly and histone gene transcription, Asf1 and the Hir complex.
Given the pleiotropic nature of mutants lacking these functions, as
well as the documented role of Asf1 and the Hir complex in histone
gene regulation (Osley and Lycan 1987; Sutton et al. 2001; Xu et al.
1992), these double mutant lethalities are not surprising. Several ad-
ditional genes were identiﬁed in the screen for double-mutant lethality
(Tables 3 and 4), and the results suggest that functional overlaps also
exist between Spt10 and both the Elongator complex and the Ino80
complex. As there are no known roles for SAGA, Elongator, or Ino80
in histone gene expression, further studies of these interactions will be
required to understand whether the essential process in which Spt10
and these other factors participate involves histone gene expression or
a previously uncharacterized role for Spt10.
The suppressors of the spt10D growth defect led us to conclude
that perturbations at multiple points of the cell cycle can suppress the
slow growth of spt10D mutants. Although it seems paradoxical that an
impairment of cell-cycle progression would enhance growth, there is
precedent for a defect in one process suppressing a defect in a related
process. For example, a cold-sensitive spt5 mutation is suppressed
with 6-azauracil, which decreases the rate of transcription elongation
(Hartzog et al. 1998). Furthermore, perturbations in multiple different
cell cycle phases can suppress a silencing defect at the S. cerevisiae
silent mating type loci and telomeres (Laman et al. 1995).
One model to explain our ﬁndings is that spt10D mutants grow
slowly due to the shortage of a factor or factors necessary for normal
Figure 6 Nongenetic means of suppressing the spt10D slow growth
phenotype. (A) Fivefold dilutions were made as in Figure 3, then spot-
ted onto YPD medium or YPD + 25 mM HU. Pictures were taken after 2
d. Strains were WT (FY2200), spt10D (FY2924), and mec1D sml1D
(FY2967). mec1D sml1D mutants are hypersensitive to HU. (B) Wild-
type (FY2200) and spt10Δ (FY2924) strains were subjected to ﬁvefold
serial dilutions as in Figure 3 and grown on YPD medium for two days
or on YP + 3% glycerol medium for 5 d.
Figure 7 mRNA abundance for the core histone genes in growth suppressor strains. RNA was isolated and reverse transcribed, and real-time PCR
with gene-speciﬁc primers (Table 2) was used to quantitate histone mRNA levels for (A) HTA1 and HTA2; (B) HTB1 and HTB2; (C) HHT1 and HHT2;
and (D) HHF1 and HHF2. All values were normalized to ACT1 mRNA levels and are shown relative to wild type, which was assigned a value of 1.
Shown is the mean 6 SEM for at least three independent experiments. Strains were wild type (FY2200 and FY1856), spt10D (FY2924 and FY2938),
spt21D (FY2816 and FY2817), hsl7D spt10D (FY2930 and FY2950), nap1D spt10D (FY2931 and FY2968), bck2D spt10D (FY2932 and FY2969),
lsm1D spt10D (FY2933 and FY2970), hsl7D lsm1D spt10D (FY2941 and FY2971), bck2D lsm1D spt10D (FY2944), hsl7D nap1D bck2D lsm1D spt10D
(FY2949 and FY2972), hsl7D (FY2934 and FY1924), nap1D (FY2935, FY2973), bck2D (FY2936, FY2974), and lsm1D (FY2937, FY2975).
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limitation, either by allowing more time for the factor to be produced,
or by adjusting the relative levels of factors with which it interacts.
Considering the well-characterized role of Spt10 in activating histone
gene transcription, obvious candidates for such factors are histone
proteins. We note that histone levels are clearly a factor in spt10D
growth, as a plasmid that encodes all four core histones (with the
HTA1-HTB1 and HHT1-HHF1 loci) restores spt10D growth to nearly
wild-type levels (Eriksson et al. 2005; Silva et al. 2012). However, we
found that suppressors of the spt10D growth defect do not suppress
the spt10D defect in histone mRNA levels, suggesting that the slow
growth can be affected by other routes, possibly independent of his-
tone gene transcription. Alternatively, the suppressors might partially
alleviate the requirement for normal histone levels.
Left unresolved by these and other studies of Spt10 is the role of
the Spt10 acetyltransferase domain. While it is required for Spt10
function (Hess et al. 2004), its target(s) remain unknown. The eluci-
dation of these targets will go a long ways toward helping us under-
stand the roles of Spt10 in growth.
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